Oligonucleotides Containing Cyanuric Acid Nucleoside
Chem. Res. Toxicol., Vol. 12, No. 7, 1999 631
Syn th etic P r oced u r es. (1) 1-(2-Deoxy-r,â-D-er yth r o-p en -
tofu r a n osyl)cya n u r ic Acid (1 a n d 2). A mixture of 2,4,6-
trihydroxy-1,3,5-triazine (330 mg, 2 mmol), 2-deoxy-3,5-di-O-p-
toluoyl-D-erythro-pentofuranosyl chloride (14) (800 mg, 2 mmol),
potassium nonafluorobutanesulfonate (1625 g, 2.4 equiv), hex-
amethyldisilazane (0.295 mL, 0.8 equiv), and trimethylsilyl
chloride (0.785 mL, 3.1 equiv) was refluxed in 20 mL of
anhydrous acetonitrile for 16 h, under conditions of moisture
exclusion. The course of the reaction was followed by TLC
(CHCl3/MeOH, 90/10, v/v). After evaporation of the solvents to
dryness, the residue was taken up in CHCl3 and washed
successively with saturated NaHCO3 and water. The major
products corresponding to the mixture of R and â anomers of
the 3′,5′-diprotected nucleoside (Rf ) 0.48) were not isolated,
but directly submitted to alkaline deprotection. Thus, the
glycosylation mixture was placed in a 1% NaOH methanol
solution (50 mL) which was stirred for 1 h at room temperature.
Solvents were removed by evaporation, and the resulting residue
was dissolved in water (50 mL), prior to being washed with
diethyl ether (50 mL) and chloroform (50 mL). The two anomers
1 and 2 were then purified on a short silica gel column that
was eluted with a step gradient of MeOH in CHCl3 (from 0 to
20%): yield of 270 mg (55%); 1/2 R/â (from integration of the
HPLC and NMR peaks area of the anomeric mixture); Rf ) 0.53
(70/30 CHCl3/MeOH); λmax (H2O, pH 7) 220 nm (shoulder);
ESI-MS (negative mode) m/z 244.22 [M - H]- (calcd mass
245.19).
For â anomer 1: 1H NMR (400.13 MHz, D2O) δ 11.39 (s, 2H,
NH), 6.64 (dd, J ) 5.3 and 8.6 Hz, 1H, H-1′), 4.63 (m, 1H, H-3′),
4.02 (m, 1H, H-4′), 3.93 (m, 1H, H-5′), 3.85 (m, 1H, H-5′′), 2.96
(m, 1H, H-2′), 2.35 (m, 1H, H-2′′); 13C NMR (100.61 MHz,
DMSO-d6) δ 149.50 (2C, C-2 and C-6), 148.70 (1C, C-4), 87.59
(1C, C-4′), 82.04 (1C, C-1′), 71.09 (1C, C-3′), 62.46 (1C, C-5′),
36.85 (1C, C-2′).
For R anomer 2: 1H NMR (400.13 MHz, D2O) δ 11.39 (s, 2H,
NH), 6.55 (pseudo-t, J ) 7.6 and 7.5 Hz, 1H, H-1′), 4.43 (m, 1H,
H-3′), 4.40 (m, 1H, H-4′), 3.91 (m, 1H, H-5′), 3.77 (m, 1H, H-5′′),
2.77 (m, 1H, H-2′), 2.72 (m, 1H, H-2′′); 13C NMR (100.61 MHz,
DMSO-d6) δ 149.69 (2C, C-2 and C-6), 148.70 (1C, C-4), 85.63
(1C, C-4′), 81.74 (1C, C-1′), 70.40 (1C, C-3′), 61.50 (1C, C-5′),
36.32 (1C, C-2′).
Ma ter ia ls a n d Meth od s
Gen er a l P r oced u r es a n d Ma ter ia ls. 2,4,6-Trihydroxy-
1,3,5-triazine (cyanuric acid) was from Fluka (Buchs, Switzer-
land). The silica gel (70-200 µm) used for the low-pressure
column chromatography was purchased from SDS (Peypin,
France). TLC was carried out on Merck DC Kieselgel 60 F-254
plastic sheets (Darmstadt, Germany). Acetonitrile and methanol
(HPLC grade) were obtained from Carlo Erba (Milan, Italy).
Buffers for high-performance liquid chromatography (HPLC)
were prepared using water purified with a Milli-Q system
(Milford, MA). The porous graphitized Hypercarb carbon column
(98.5% carbon, particle size of 5 µm, porosity of 250 Å, 100 mm
× 3 mm i.d.) was from Shandon (Runcorn, Cheschire, U.K.),
whereas the Hypersil ODS column (5 µm, 4.6 mm × 250 mm
i.d.) was purchased from Interchim (Montluc¸on, France). Un-
modified deoxyribonucleoside phosphoramidites, protected
with phenoxyacetyl for dAdo, isopropylphenoxyacetyl for dGuo,
and acetyl for dCyd, were from Glen Research (Sterling, VA).
Functionalized CPG supports, involving the phenoxyacetyl
protective group for dAdo and dGuo and the isobutyryl pro-
tective group for dCyd, were purchased from Sigma (St. Louis,
MO). 8-OxodGuo-containing oligonucleotide was prepared
using a commercial phosphoramidite monomer from Glen
Research.
En zym es. Calf spleen phosphodiesterase (CSPDE) and snake
venom phophodiesterase (SVPDE) were purchased from Boe-
hringer Mannheim (Mannheim, Germany). Fpg and endonu-
clease III were kind gifts from S. Boiteux (CEA, Fontenay-aux-
Roses, France). Nuclease P1 (Penicillium citrium) and phospha-
tase alkaline were purchased from Sigma. T4 polynucleotide
kinase was obtained from Pharmacia Biotech (Uppsala, Swe-
den). Klenow fragment (exo-) of Escherichia coli DNA poly-
merase I was from Amersham (Buckinghamshire, U.K.).
Ma ss Sp ectr om etr y Mea su r em en ts. FAB (fast atom bom-
bardment) mass spectrometry analyses were carried out on a
VG ZAB 2-EQ apparatus (Manchester, U.K.). The samples were
dissolved in either a glycerol or NBA matrix prior to be analyzed.
All modified and unmodified oligonucleotides were character-
ized by electrospray ionization mass spectrometry measure-
ments (ESI-MS) on a Micromass Platform model 3000 spectro-
photometer (Manchester, U.K.). Typically, 0.1 OD of the sample
was dissolved in a solution of acetonitrile and water (50/50, v/v)
containing 1% triethylamine prior to be analyzed in the negative
mode. The modified nucleoside dY and its 5′-DMTr-protected
derivative were analyzed by ESI-MS in both the negative and
positive modes. For the positive mode analysis, the sample was
dissolved in a solution of acetonitrile and water (50/50, v/v) that
contained 0.5% formic acid.
MALDI mass spectra were obtained with a commercially
available time-of-flight mass spectrometer (Voyager-DE, Per-
septive Biosystems, Framingham, MA) equipped with a 337 nm
nitrogen laser and a pulsed delay source extraction. Spectra
were recorded from 256 laser shots with an accelerating voltage
of 25 kV in the linear and positive modes. For the matrix, a
mixture of 3-hydroxypicolinic acid and picolinic acid in a 4/1
(w/w) ratio was dissolved in an aqueous acetonitrile solution
(50%) that contained 0.1% TFA and a small amount of Dowex-
50W 50X8-200 cation-exchange resin (Sigma). Typically, 1 µL
of the sample was added to 1 µL of the matrix, and the resulting
solution was stirred. The resulting sample was then placed on
the top of the target plate and allowed to dry by itself. The
spectra were calibrated with a 1 pmol/µL solution of myoglobin
(m/z 16 952), using the same conditions that were described for
the analysis of oligonucleotides.
La belin g of Oligon u cleotid es. Oligonucleotides (10 pmol)
were labeled at the 5′-terminus with 10 µCi of [γ-32P]ATP (2
pmol, 10 mCi/mL) from Amersham upon incubation with T4
polynucleotide kinase (9.5 units) in 10 µL of supplied buffer at
37 °C for 30 min. The reaction was quenched by addition of 1
µL of a 0.5 M EDTA solution (pH 8). Unincorporated [γ-32P]-
ATP was removed by purification of the oligonucleotide on a
MicroSpin column (Pharmacia Biotech).
(2) 1-[2-Deoxy-5-(4,4′-dim eth oxytr ityl)-r,â-D-er yth r o-p en -
tofu r a n osyl]cya n u r ic Acid (3 a n d 4). The anomeric mixture
of compounds 1 and 2 (0.41 mmol, 100 mg) was dried by
repeated coevaporation with anhydrous pyridine and then
dissolved in pyridine (10 mL). The solution was cooled in an
ice/water bath and kept under an argon atmosphere. Then, 4,4′-
dimethoxytrityl chloride (DMTrCl, 195 mg, 1.4 equiv) was added
under stirring. After 1 h, the cooling bath was removed and the
reaction was continued at room temperature overnight. Subse-
quently, 1 mL of methanol was added and the resulting solvent
mixture was evaporated. The oily residue was dissolved in ethyl
acetate (50 mL) and washed with a saturated NaHCO3 aqueous
solution (50 mL) and water (50 mL). The organic phase that
contained the two 5′-protected anomers 3 and 4 was dried over
Na2SO4 and evaporated under reduced pressure. The mixture
of R and â anomers was resolved by silica gel column chroma-
tography (0 to 5% step gradient of methanol in CHCl3 in the
presence of 1% triethylamine) to afford the title compounds 3
and 4 in a yield of 40.5 and 19%, respectively (1/2 R/â). One-
dimensional TLC analysis was performed using CHCl3/MeOH
(90/10, v/v) with 1% TEA as the solvent. The Rf values were
0.63 for the R-anomer 4 and 0.52 for the â-anomer 3: ESI-MS
(negative mode) m/z 546.09 [M - H]- (calcd mass 547).
For â anomer 3 (91 mg): 1H NMR (400.13 MHz, acetone-d6)
δ 7.62-6.85 (m, 12H, aromatic H of DMTr), 6.56 (dd, J ) 4.6
and 8.9 Hz, 1H, H-1′), 4.49 (m, 1H, H-3′), 3.98 (m, 1H, H-4′),
3.81 (s, 6H, OCH3), 3.39 (m, 1H, H-5′), 3.23 (m, 1H, H-5′′), 2.76
(m, 1H, H-2′), 2.21 (m, 1H, H-2′′).
For R anomer 4 (43 mg): 1H NMR (400.13 MHz, acetone-d6)
δ 7.60-6.78 (m, 12H, aromatic H of DMTr), 6.49 (pseudo-t, 1H,
H-1′), 4.44 (m, 1H, H-3′), 4.42 (m, 1H, H-4′), 3.80 (s, 6H, OCH3),